AXNX | tickerfilter.com

Fundamental analysis

16%

Profitability 0%

Dept financing 8%

Liquidity 75%

Performance 19%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.31%

1 Month

1.06%

3 Months

3.03%

6 Months

1.03%

1 Year

19.13%

2 Year

-2.49%

Key data

Stock price

$69.14

P/E Ratio

-2,066.38

DAY RANGE

N/A - $69.23

EPS

-$0.03

52 WEEK RANGE

$48.30 - $69.68

52 WEEK CHANGE

$0.19

MARKET CAP

3.536 B

YIELD

N/A

SHARES OUTSTANDING

51.118 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/06/2024

BETA

0.83

PUBLIC FLOAT

AVERAGE 10 VOLUME

$229,964

AVERAGE 30 VOLUME

$294,642

Company detail

CEO: Raymond Cohen
Region: US
Website: https://www.axonicsmodulation.com/
Employees: 353
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.

AXNX - Axonics Inc